Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.600
+0.019 (3.24%)
Nov 21, 2024, 11:44 AM EST - Market open
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $35.47 million as of November 21, 2024. Its market cap has increased by 63.95% in one year.
Market Cap
35.47M
Enterprise Value
-37.69M
1-Year Change
63.95%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $35.47M, a decrease of -90.29%. That is a compound annual growth rate of -49.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 34.35M | 50.83% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 36.03M |
| Carisma Therapeutics | 36.01M |
| HCW Biologics | 35.83M |
| Beyond Air | 35.49M |
| FibroGen | 35.27M |
| Precision Optics Corporation | 33.97M |
| Tonix Pharmaceuticals Holding | 33.93M |
| Estrella Immunopharma | 33.31M |